No To Hattatsu最新文献

筛选
英文 中文
[Historiae]. [历史]。
No To Hattatsu Pub Date : 2020-10-30 DOI: 10.2307/j.ctv16qjz5t.9
N. Morota
{"title":"[Historiae].","authors":"N. Morota","doi":"10.2307/j.ctv16qjz5t.9","DOIUrl":"https://doi.org/10.2307/j.ctv16qjz5t.9","url":null,"abstract":"The escape is the practice that changes a person into a fugitive. Such escape might have been induced by economic, political and/or social reasons. Generally, two terms were used to identify people who ran away from their habitat: hapirum and munnabtum. In this paper, I will follow the viewpoints of Bottéro and Rowton to denote that the former were social rootless people while the latteraccording to Buccellatiwere politically displaced individuals. These stances do not agree with Durand’s perspective about such social actors located within the political scenario at Mari. This author defines and re-defines them throughout several papers to finally understand the hapirum as political adversaries and the munnabtum as emigrants due to specific situations. Based on the analysis of the approaches of all the mentioned authors, we get to understand that the term hapirum would explain the situation of emigrant/immigrant people. The alleged political opposition of these social actors was not the source of their displacement but one of the consequences resulted from it. Thereafter, the political aspect that would sheathe the hapirum would be a result of their need and not the motive. Conversely, the term munnabtum would actually imply a political bias that could be traced out by finding them isolated or hunted individually by the political power. Thus, the aim of this paper is to set out the complexity that the translation of certain terms involves and, considering the cases 1 Una primera versión de este trabajo fue presentada en el Workshop “Convegno internazionale. Costruzione / distruzione / rafforzamento dell’identità. Tolleranza, integrazione e guerra nelle società del Vicino Oriente antico e altre culture”, \"Sapienza\" Universidà di Roma, 12 de abril de 2013.","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"47 4 1","pages":"256"},"PeriodicalIF":0.0,"publicationDate":"2020-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43118188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
[Introductory remarks]. [介绍性发言]。
No To Hattatsu Pub Date : 2019-02-14 DOI: 10.1017/9781108557917.013
T. Kubota, H. Fukuoka
{"title":"[Introductory remarks].","authors":"T. Kubota, H. Fukuoka","doi":"10.1017/9781108557917.013","DOIUrl":"https://doi.org/10.1017/9781108557917.013","url":null,"abstract":"","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"47 3 1","pages":"212-4"},"PeriodicalIF":0.0,"publicationDate":"2019-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45424936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical characteristics of early juvenile GM2 gangliosidosis: a case report]. [少年早期GM2神经节脂质沉积症1例]。
No To Hattatsu Pub Date : 2017-05-01
Hiroya Ono, Chitose Sugiura, Aya Narita, Koyo Ohno, Yoshiaki Saito, Yoshihiro Maegaki, Nagako Murakami, Eiji Nanba
{"title":"[Clinical characteristics of early juvenile GM2 gangliosidosis: a case report].","authors":"Hiroya Ono,&nbsp;Chitose Sugiura,&nbsp;Aya Narita,&nbsp;Koyo Ohno,&nbsp;Yoshiaki Saito,&nbsp;Yoshihiro Maegaki,&nbsp;Nagako Murakami,&nbsp;Eiji Nanba","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We describe the case of a 15-year-old male with early juvenile type GM2 gangliosidosis. He first manifested with progressive clumsiness in his extremities at the age of 1.5 years, followed by motor regression. Intellectual disability became evident as late as age 6 years. This discrepancy along with rapid motor deterioration after varicella infection, lack of startle response or macrocephaly, and paucity of myoclonus were thought to be characteristic of juvenile GM2 gangliosidosis. In contrast to the cerebellar atrophy as the initial finding in usual juvenile GM2 gangliosidosis, magnetic resonance imaging revealed initially cerebral, and subsequently cerebellar, progressive atrophy. Autistic behavioral problems, including phonophobia, during intellectual regression in this patient was also unusual in juvenile GM2 gangliosidosis. Thus, recognition of these features would prompt proper diagnosis and insights into the pathomechanisms of GM2 gangliosidosis.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"49 3","pages":"203-6"},"PeriodicalIF":0.0,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36402603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide]. 托吡酯成功治疗乙酰唑胺难治性特发性颅内高压1例。
No To Hattatsu Pub Date : 2017-05-01
Marie Noda, Yuri Sonoda, Megumi Takemoto, Ryutaro Kira
{"title":"[Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].","authors":"Marie Noda,&nbsp;Yuri Sonoda,&nbsp;Megumi Takemoto,&nbsp;Ryutaro Kira","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 6-year-old girl experienced nausea and vomiting for 3 weeks and double vision for 1 week prior to her first visit to our hospital. She had bilateral ophthalmoplegia from sixth cranial nerve palsy and papilledema. Her brain MRI showed normal brain parenchyma. The lumbar cerebrospinal fluid (CSF) opening pressure was 1000 mm of water measured with normal CSF contents. From these findings, she was diagnosed with idiopathic intracranial hypertension (IIH). Initial lumbar puncture (LP) immediately improved her symptoms, but acetazolamide, a first line drug for the treatment of IIH, failed to maintain the remission, and three more periodical LP were required to relieve her symptoms every 2 weeks. After the fourth LP, acetazolamide was switched to a second line drug for IIH, topiramate, which was found to be highly effective in controlling IIH in a short time period. The long process of IIH causes vision loss, therefore, its prompt treatment is vital. In cases refractory to medical treatment, surgical treatments such as CSF shunt are considered. Acetazolamide is used in most IIH cases after the initial diagnosis, but in this case, it was ineffective, and topiramate was highly effective. Both acetazolamide and topiramate are inhibitors of carbonic anhydrase isoforms involved in CSF secretion. Inhibition of choroid plexus carbonic anhydrase by these drugs leads to decreased CSF secretion and the consequent control of intracranial pressure. Higher isoform specificity and increased lipophilic nature of topiramate, which are advantageous for passing through the blood brain barrier, may be the reasons for better activity than acetazolamide, at least in the present case. Topiramate might be effective and should be considered for refractory IIH cases before surgical treatments.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"49 3","pages":"207-10"},"PeriodicalIF":0.0,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36402604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Irreversible cerebral ischemia caused by febrile status epilepticus in Sturge-Weber syndrome type III]. [Sturge-Weber综合征III型患者发热性癫痫持续状态所致不可逆脑缺血]。
No To Hattatsu Pub Date : 2017-03-01
Yuri Sakaguchi, Tomohide Goto, Sahoko Miyama
{"title":"[Irreversible cerebral ischemia caused by febrile status epilepticus in Sturge-Weber syndrome type III].","authors":"Yuri Sakaguchi,&nbsp;Tomohide Goto,&nbsp;Sahoko Miyama","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We report a 9-year-old girl with Sturge-Weber syndrome (SWS) type III, whose motor function deteriorated after an episode of febrile status epilepticus. The patient had leptomeningeal angiomas in the left temporal, occipital, and parietal lobes. Complex partial seizures, which started at 8 months, were controlled by antiepileptic medications. At 9 years of age, she developed irreversible ischemic lesions in the left temporal and occipital regions after the febrile status epilepticus and her motor function deteriorated. In addition to antiepileptic medications, aspirin therapy was started.SWS type III is a rare disorder characterized by leptomeningeal angiomatosis without facial nevus. In addition to the chronic ischemia in the affected cortex, epileptic seizures result in a phased progression of ischemia in SWS. Although the patient’s complex partial seizures had been well-controlled, a single episode of febrile status epilepticus resulted in permanent brain lesions. The impairment of appropriate hemodynamic response to status epilepticus, together with venous hypertension in the affected side in SWS may have caused the cerebral infarction in our case. Seizure control is crucial to improving the neurological prognosis of SWS.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"49 2","pages":"126-9"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36402098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The characteristics of social skills, school maladjustment and stress responses in junior high school students with autism spectrum disorder]. 初中生孤独症谱系障碍的社交技能、学校适应不良和应激反应特征
No To Hattatsu Pub Date : 2017-03-01
Junko Okajima, Noriko Kato, Yuko Yoshitomi, Rie Kanaya, Ryoichi Sakuta
{"title":"[The characteristics of social skills, school maladjustment and stress responses in junior high school students with autism spectrum disorder].","authors":"Junko Okajima,&nbsp;Noriko Kato,&nbsp;Yuko Yoshitomi,&nbsp;Rie Kanaya,&nbsp;Ryoichi Sakuta","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to test difference between the social skills of adolescents with autism spectrum disorder (ASD) and their typically developing students.\"</p><p><strong>Methods: </strong>Participants were 299 junior high school students from public schools. The group included 19 junior high school students with ASD. Participants responded to self-rated questionnaire on social skills, school maladjustment, and stress.</p><p><strong>Results: </strong>Results showed that adolescent with ASD had mental health difficulties (in stress responses and school maladjustment) and poor social skills as compared to their typically developing peers. A cluster analysis was conducted by dividing the participants into the following four groups based on their z-scores on the social skills scale: “low skill type”, “low skill of continuing relationship type”, “well-balance type”, and “inactive type”. A Chi-square test revealed that a greater portion of the ASD group included students belonging to the “inactive, authoritative and low type” and “inactive type” cluster as compared to the typically developing group.</p><p><strong>Conclusions: </strong>The Adolescent with ASD have social skills characterized by inactive type that poor entry skills.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"49 2","pages":"120-5"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36402097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Non-invasive positive pressure ventilation during the management of severe spinal muscular atrophy type I]. [无创正压通气治疗重症I型脊髓性肌萎缩]。
No To Hattatsu Pub Date : 2017-03-01
Kenji Inoue, Nobusuke Kimura, Yoshihisa Higuchi, Makiko Nakamoto, Tsuyoshi Imai, Hisahide Nishio
{"title":"[Non-invasive positive pressure ventilation during the management of severe spinal muscular atrophy type I].","authors":"Kenji Inoue,&nbsp;Nobusuke Kimura,&nbsp;Yoshihisa Higuchi,&nbsp;Makiko Nakamoto,&nbsp;Tsuyoshi Imai,&nbsp;Hisahide Nishio","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Patients with spinal muscular atrophy type Ⅰ (SMA Ⅰ) with the onset before the age of 3 months are considered as severe form of SMA Ⅰ (severe SMA Ⅰ) and have poor prognosis. Here, we report the efficacy of non-invasive positive pressure ventilation (NPPV) in a patient with severe SMA Ⅰ. She was born with generalized hypotonia and feeding difficulties, and had SMN1 gene mutations (the deletion of exons 7 and 8). At 1 month of age, she was intubated because of respiratory failure due to a respiratory tract infection, and extubation proved difficult. Her parents decided that NPPV and a mechanical in-exsufflator (MI-E) should be used for respiratory management rather than a tracheotomy. The NPPV improved her peripheral coldness, cold sweats, chest wall movement, and heart rate and enabled her to sleep well. At 1 year and 2 months, chest computed tomography revealed mild pneumonia and did not show any atelectasis. The NPPV facilitated discharge, and the patient had a good quality of life (QOL) from the point of view of voice production, the ability to move easily, the simplicity of bathing, and the low level of discomfort she experienced. However, she suffered repeated episodes of aspiration pneumonia and airway obstruction (by sputum) after 11 months of age. Thereafter, she required continuous NPPV and high-span inspiratory positive airway pressure (21 cmH2O). At 1 year and 4 months, she died of respiratory failure at home. As her bulbar weakness worsened, respiratory management with NPPV became difficult. However, the long-term use of NPPV together with high-span positive inspiratory pressure plus positive end-expiratory pressure, and a high-pressure MI-E at an early age might improve respiratory management outcomes and patient prognosis. In our case, NPPV was effective at improving ventilation and preventing atelectasis and helped to provide the patient with a good QOL.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"49 2","pages":"141-4"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36400519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The efficacy of intravenous alendronate for osteoporosis in patients with severe motor intellectual disabilities]. 【静脉注射阿仑膦酸钠治疗重度运动智力障碍患者骨质疏松的疗效观察】。
No To Hattatsu Pub Date : 2017-03-01
Yoshimi Kaga, Sayaka Ishii, Itaru Kuroda, Yuko Kamiya, Kousuke Nakamura, Hideaki Kanemura, Kanji Sugita, Masao Aihara
{"title":"[The efficacy of intravenous alendronate for osteoporosis in patients with severe motor intellectual disabilities].","authors":"Yoshimi Kaga,&nbsp;Sayaka Ishii,&nbsp;Itaru Kuroda,&nbsp;Yuko Kamiya,&nbsp;Kousuke Nakamura,&nbsp;Hideaki Kanemura,&nbsp;Kanji Sugita,&nbsp;Masao Aihara","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Bone fractures in patients with severe motor and intellectual disabilities (SMIDs) have become an important problem to be solved. These fractures may result from disuse osteoporosis. Bisphosphonate administration is generally the most established treatment for patients with osteoporosis. However, traditional oral bisphosphonate use is associated with esophagitis as a side effect and may increase the risk of reflux esophagitis for bedridden patients. Intravenous alendronate, one of the bisphosphonates, was released in 2012 in Japan. Though it is appropriate for patients with SMIDs, there are no reports about the effects of intravenous alendronate on osteoporosis in SMID patients. Therefore, the efficacy of intravenous alendronate for osteoporosis was investigated in SMID patients.</p><p><strong>Methods: </strong>The subjects were 62 SMID patients with osteoporosis (20 to 60 years old) in our hospital. They were divided two groups, bisphosphonate treatment group (32 patients) and age-matched controls (30 patients). Patients in bisphosphonate treatment groups were given 900μg intravenous alendronate once a month. All patients were also administered oral vitamin D3. Serial bone density, bone metabolism markers, and existence of fractures were compared in both groups before and after treatment (6 months, 1 years, and 2 years).</p><p><strong>Results: </strong>In bisphosphonate treatment group, the change rate of bone density was significantly increased and bone metabolism markers were improved at 6 months and 1 year after starting treatment. After a year, 16 patients in treatment group changed into other treatments, and 12 controls started bisphosphonate treatment. In remaining treatment group (16 patients), the change rate of bone density and bone metabolism markers were improved significantly at 2 years after starting treatment. A patient in control group had a bone fracture, but no patients in bisphosphonate treatment groups had fractures or severe adverse effects.</p><p><strong>Conclusion: </strong>Intravenous alendronate is an effective treatment for osteoporosis in SMID patients.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"49 2","pages":"113-9"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36402096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A case of West syndrome with a deletion at chromosome 2q24.3-q31.3]. 【西氏综合征伴2q24.3-q31.3染色体缺失1例】。
No To Hattatsu Pub Date : 2017-03-01
Yuka Hattori, Hisashi Kawawaki, Asako Horino, Hitomi Thuji, Megumi Nukui, Ichiro Kuki, Shin Okazaki, Kiyotaka Tomiwa
{"title":"[A case of West syndrome with a deletion at chromosome 2q24.3-q31.3].","authors":"Yuka Hattori,&nbsp;Hisashi Kawawaki,&nbsp;Asako Horino,&nbsp;Hitomi Thuji,&nbsp;Megumi Nukui,&nbsp;Ichiro Kuki,&nbsp;Shin Okazaki,&nbsp;Kiyotaka Tomiwa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A male infant suffered from partial seizures at four months of age, and developed West syndrome at eight months of age. ACTH therapy was effective for the West syndrome. However, partial seizures recurred at 14 months of age, which could not be sufficiently controlled with an anti-epileptic drug. A characteristic facial appearance, great toe abnormalities, and developmental retardation were noted. An interstitial deletion of 2q was detected by chromosomal G-banding and array comparative genomic hybridization (CGH) confirmed the deletion as arr 2q24.3q31.3 (166,303,447-180,982.972) ×1 (build19). He presented with clinical findings similar to those of the recently defined 2q31.1 deletion syndrome. The deletion extended to the SCN1A gene, a gene responsible for Dravet syndrome, mapped to the 2q24.3 region. No deletion was noted in the adjacent SCN2A gene. Thus, for interstitial deletions, detailed breakpoints should be identified by array CGH. The frequency of epilepsy varies with deletion ranges in the 2q24-q31 region, suggesting that deletions in the SCN1A gene deletion, as well as in the 2q31.1 region, are involved in the development of West syndrome.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"49 2","pages":"131-5"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36402099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The pitfalls of using diagnosis and treatment guidelines for patients with juvenile myasthenia gravis]. 【青少年重症肌无力患者使用诊疗指南的误区】。
No To Hattatsu Pub Date : 2017-03-01
Keiko Ishigaki
{"title":"[The pitfalls of using diagnosis and treatment guidelines for patients with juvenile myasthenia gravis].","authors":"Keiko Ishigaki","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Even though evidence-based clinical guidelines are useful for the management of common diseases, there are several problems in applying such guidelines to patients with rare diseases. First, there are few references providing high-level evidence pertaining to such diseases, and randomized control as well as large cohort studies are lacking. Most grades of recommendation are “suggest” rather than “recommend” or, often, are based on “expert opinion”. Juvenile myasthenia gravis (MG) is a rare disease and has mainly been reported in East Asia. In 2014, evidence-based clinical guidelines for MG diagnosis and treatment were published in Japan. Since references were scarce, these guidelines were also based on expert opinions such as those of a few institutes or specialists who had gathered most of the patients in Japan. The guidelines might be of limited usefulness for general pediatricians or pediatric neurologists with no MG experience, and we should be aware of strengths and pitfalls when applying such guidelines. For example, while knowing when to start steroid administration or the appropriate steroid dose is feasible, the optimal timing of switching from an anti-cholinesterase drug to a steroid or adding an anti-inflammatory drug and how to decrease or stop steroid administration cannot be ascertained from the guidelines. The lack of references with high-level evidence makes the guidelines difficult to apply, since this would be the information most desired by clinicians. Another problem is that a recommendation may easily be reversed if opposing results are obtained in a single study of a rare disease. Thymectomy was recognized as not being beneficial for MG without thymoma but one recent study reversed this recommendation in the guidelines. Herein, we discuss pitfalls in applying diagnostic and treatment guidelines in patients with juvenile MG.</p>","PeriodicalId":39367,"journal":{"name":"No To Hattatsu","volume":"49 2","pages":"87-93"},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36402095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信